8-K
filed October 3, 2025, 7:59 PM ET
ticker IDAI
CIK 0001718939
other material
confidence high
sentiment neutral
materiality 0.60
T Stamp raises $5.6M through ATM equity offering at ~$3.56/share
T Stamp Inc
- Raised $5.6M from sale of common stock under ATM agreement with Maxim Group LLC.
- Shares sold at volume-weighted average price of $3.56/share from July 8 to Oct 2, 2025.
- Nearly reached maximum of $6.196 million under S-3 registration statement.
- ATM offering conducted under Equity Distribution Agreement dated Feb 25, 2025.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001718939-25-000145
- form_type
- 8-K
- ticker
- IDAI
- cik
- 0001718939
- company_name
- T Stamp Inc
- filed_at
- 2025-10-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.246504+00:00
- generated_at
- 2026-05-17T04:48:00.256658+00:00
- sec_items
- ["8.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001718939-25-000145
- json_url
- https://secwatch.observer/filing/0001718939-25-000145.json
- markdown_url
- https://secwatch.observer/filing/0001718939-25-000145.md
- text_url
- https://secwatch.observer/filing/0001718939-25-000145.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1718939/000171893925000145/0001718939-25-000145-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1718939/000171893925000145/idai-20251003.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
NRXP
NRx Pharmaceuticals proposes public offering of common stock; terms not set
NRX Pharmaceuticals, Inc.
June 2, 2026, 5:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
XMTR
Xometry announces public offering of 2.65M shares at $85.00; expected net proceeds $215.2M
Xometry, Inc.
June 2, 2026, 5:26 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
ARVN
Arvinas to out-license ARV-806 after completing Phase 1 dose escalation
ARVINAS, INC.
June 2, 2026, 4:39 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
CEG
Constellation Energy secondary offering of 11M shares with concurrent $558M share repurchase
Constellation Energy Corp
June 2, 2026, 4:15 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
JAGX
Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8
Jaguar Health, Inc.
June 2, 2026, 4:10 PM ET
other_material
Items 1.01, 3.02, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
MLI
Mueller Industries announces 2-for-1 stock split; record date June 25, 2026
MUELLER INDUSTRIES INC
June 2, 2026, 10:47 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
SLS
SELLAS Life Sciences raised $28.7M from warrant exercises in Apr-May 2026
SELLAS Life Sciences Group, Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
MBOT
Microbot Medical secures first North Carolina customer for LIBERTY robotic system
Microbot Medical Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.